RESUMEN
The cotton bollworm Helicoverpa armigera (Hubner) (Lepidoptera: Noctuidae) is one of the most serious insect pests in Australia, India and China. The larva causes substantial economical losses to legume, fibre, cereal oilseed and vegetable crops. This pest has proven to be difficult to control by conventional means, mainly due to the development of pesticide resistance. We present here the 2.5 A crystal structure from the novel procarboxypeptidase (PCPAHa) found in the gut extracts from H. armigera larvae, the first one reported for an insect. This metalloprotease is synthesized as a zymogen of 46.6 kDa which, upon in vitro activation with Lys-C endoproteinase, yields a pro-segment of 91 residues and an active carboxypeptidase moiety of 318 residues. Both regions show a three-dimensional structure quite similar to the corresponding structures in mammalian digestive carboxypeptidases, the most relevant structural differences being located in the loops between conserved secondary structure elements, including the primary activation site. This activation site contains the motif (Ala)(5)Lys at the C terminus of the helix connecting the pro- and the carboxypeptidase domains. A remarkable feature of PCPAHa is the occurrence of the same (Ala)(6)Lys near the C terminus of the active enzyme. The presence of Ser255 in PCPAHa instead of Ile and Asp found in the pancreatic A and B forms, respectively, enlarges the S1' specificity pocket and influences the substrate preferences of the enzyme. The C-terminal tail of the leech carboxypeptidase inhibitor has been modelled into the PCPAHa active site to explore the substrate preferences and the enzymatic mechanism of this enzyme.
Asunto(s)
Carboxipeptidasas/química , Precursores Enzimáticos/química , Gossypium/parasitología , Proteínas de Insectos/química , Lepidópteros/enzimología , Secuencias de Aminoácidos , Secuencia de Aminoácidos , Animales , Sitios de Unión , Carboxipeptidasas/antagonistas & inhibidores , Carboxipeptidasas/metabolismo , Cristalografía por Rayos X , Activación Enzimática , Precursores Enzimáticos/antagonistas & inhibidores , Precursores Enzimáticos/metabolismo , Humanos , Proteínas de Insectos/antagonistas & inhibidores , Proteínas de Insectos/metabolismo , Larva/enzimología , Lepidópteros/crecimiento & desarrollo , Metaloendopeptidasas/antagonistas & inhibidores , Metaloendopeptidasas/química , Metaloendopeptidasas/metabolismo , Modelos Moleculares , Datos de Secuencia Molecular , Peso Molecular , Páncreas/enzimología , Estructura Secundaria de Proteína , Estructura Terciaria de Proteína , Alineación de Secuencia , Estómago/enzimología , Especificidad por SustratoRESUMEN
Granzyme B is the prototypic member of the granzymes, a family of trypsin-like serine proteinases localized in the dense cytoplasmic granules of activated natural killer cells and cytotoxic T lymphocytes. Granzyme B directly triggers apoptosis in target cells by activating the caspase pathway, and has been implicated in the etiology of rheumatoid arthritis. Human granzyme B expressed in a baculovirus system has been crystallized without inhibitor and its structure has been determined to 3.1 A resolution, after considerably improving the diffraction power of the crystals by controlled humidity changes. The granzyme B structure reveals an overall fold similar to that found in cathepsin G and human chymase. The guanidinium group of Arg226, anchored at the back of the S1-specificity pocket, can form a salt bridge with the P1-Asp side chain of a bound peptide substrate. The architecture of the substrate binding site of granzyme B appears to be designed to accommodate and cleave hexapeptides such as the sequence Ile-Glu-Thr-Asp-/Ser-Gly present in the activation site of pro-caspase-3, a proven physiological substrate of granzyme B. These granzyme B crystals, with fully accessible active sites, are well suited for soaking with small synthetic inhibitors that might be used for a treatment of chronic inflammatory disorders.